Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Cell Therapy
  6.  » Strategies to Advance iPSC Therapies to Clinic

Strategies to Advance iPSC Therapies to Clinic

Summary: As iPSC-based cell therapies progress towards the clinic, cell therapy manufacturers are looking at innovative methodologies to drive down costs and maximize scale, safety and quality as iPSCs advance within the clinical pipeline. In this presentation, our Expert discusses efforts underway at Catalent to accelerate the path to clinic for iPSC-based therapies.


Click here to download the Webinar